Retension Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RTSN and other ETFs, options, and stocks.About RTSN
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension.
RTSN Key Statistics
Stock Snapshot
Retension Pharmaceuticals(RTSN) stock is priced at $15.25, giving the company a market capitalization of 124.89M.
As of 2026-10-23, Retension Pharmaceuticals(RTSN) stock has fluctuated between $14.59 and $16.29. The current price stands at $15.25, placing the stock +4.6% above today's low and -6.4% off the high.
The Retension Pharmaceuticals(RTSN)'s current trading volume is 77.31K, compared to an average daily volume of 211.98K.
During the past year, Retension Pharmaceuticals(RTSN) stock moved between $9.66 at its lowest and $18.64 at its peak.
During the past year, Retension Pharmaceuticals(RTSN) stock moved between $9.66 at its lowest and $18.64 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.